期刊文献+

罗哌卡因血浆浓度测定与关节腔给药经时变化 被引量:2

Determination of Ropivacaine in Plasma and the Time Dependent Change of Drug Administration via Articular Cavity
下载PDF
导出
摘要 目的建立高效液相色谱(HPLC)法测定血浆中罗哌卡因浓度并观察关节腔给药后体内血药浓度的经时变化。方法以利多卡因作为内标,用乙酸乙酯提取,以乙腈-0.025mol.L-1磷酸缓冲液(pH值3.0)(25:75)为流动相,采用Hypersil ODS(4.6mm×200mm,5μm)分离,检测波长为220nm。人工全膝关节置换术后,关节腔注射罗哌卡因150mg,于注射后0.5,1.0,1.5,2.0,2.5,4.5h取血3mL,测定罗哌卡因浓度。结果在选定的色谱条件下,罗哌卡因与血浆中的杂质及内标物分离良好。罗哌卡因血浆浓度在0.1~4.0μg.mL-1范围内线性关系良好(r=0.9995),最低检测浓度为0.02μg.mL-1(血浆浓度),日内、日间RSD<5%,血浆中罗哌卡因的提取回收率为85.2%~96.2%。关节腔用药后Cmax为(637.5±69.6)μg.L-1,tmax为(1.31±0.31)h。结论该法测定血浆罗哌卡因的血药浓度,操作简便,结果可靠、准确,重复性较好。关节腔单次注射罗哌卡因150mg,其血浓度较低,持续时间较长,为比较安全的给药方法。 Objective A RP-HPLC method for determination of ropivacaine in plasma was developed and was applied to analyze the time dependent change of ropivacaine treated via articular cavity. Methods The sample was treated by adding lidocaine as an internal standard, extraetd with ethyl acetate. Aeetonitrile and 0. 025 mol · L^-1 phosphate buffer solution (pH3.0) (25 : 75 ) were used as the mobile phase, Hypersil ODS(4.6 mm × 200 mm,5μm)as the stationary phase, and the detection wavelength was 220 nm. After the whole knee arthroplasty, 150 mg ropivaeaine was administered into articular cavity, the concentration of which was determined at the following time, 0.5,1.0,1.5,2.0,2.5,4.5 h. Results Under the selected spectrum condition, ropivacaine was completely separated from the internal standard and the impurities of plasma. The linear range was from 0.1 - 4.0 μg· mL^-1 with r = 0. 999 5. The detection limit was 0. 02 μg - mL^-1. And the relative standard deviation of inner-day and inter-day was less than 5%. The recovery rate of extraction was between 85.2 - 96.2%. The maximum concentration of ropivacaine in the plasma was (637.5 ± 69.6) μg · L^-1 , and the peak of the time was (1.31 -0. 31 ) h. Conclusion The method for determination of ropivacaine in plasma is simple, accurate, reliable and with a good reproducibility. Sigle administration of 150 mg ropivaeaine via articular cavity shows lower drug plasma concentration and longer sustained time, which is a safe way for drug administration.
出处 《医药导报》 CAS 2009年第1期33-36,共4页 Herald of Medicine
关键词 罗哌卡因 利多卡因 血药浓度 关节腔 色谱法 高效液相 反相 Ropivacaine Lidocaine Blood drug level Articular cavity RP-HPLC
  • 相关文献

参考文献11

二级参考文献40

  • 1王平全,陆国红,周贤飚,沈金芳,陈曙霞,梅尚文,陈美芳.苦参碱的人体药代动力学[J].药学学报,1994,29(5):326-329. 被引量:24
  • 2王荫昌,严常开.高效液相色谱法测定人血浆中布比卡因浓度[J].中国医院药学杂志,1989,9(4):150-151. 被引量:2
  • 3[1]Liu BG,Zhuang XL,Li ST,et al The effect of ropivac- aine on sodium currents in dorsal horn neurons of neonatal rats[J]. Anesth & Analg,2000,90(5); 1 034.
  • 4[2]Santos AC,DeArmas PI Systemic toxicity of levobupiv- acine,bupivacaine,and ropivacaine during continuous intravenous infusion to nonpregnant and pregnant ewes[J]. Anesthesiology,2001,95(5); 1 256.
  • 5[3]Porter [J].M,Markos F,Snow HM et al Effect of respir- atory and metabolic PH changes and hypoxia on ropivacaine- induced cardiotoxicity in dogs[J]. British [J].ournal of Anaesthesiology,2000,84(1); 92.
  • 6Lippincott, Williams, Wilkins. A comparison of the placental transfer of ropivacaine versus bupivacaince [ J ]. Anesth Analg( Baltimore), 1999,89( 3 ) :703.
  • 7解大建,北京医科大学学报,1986年,18卷,275页
  • 8谢大建 吴新民 许幸.硬膜外阻滞时罗哌卡因和布比卡因的药动力学[J].中华麻醉学杂志,1998,19(8):459-459.
  • 9Rifai N, Hsin O, Hope T, et al. Simuhaneous measurement of plasma ropivacaine and bupivacaine concentrations by HPLC with UV detection[J]. Ther Drug Monit,2001,23(2) : 182.
  • 10Reif S, Le-Corre, P, Dollo G, et al. High-performance liquid chromatographic determination of ropivacaine 3-hydroxy-ropivacaine and 2', 6'pipecoloxylipide in plasma[J] .J Chromatogr B, 1998,719:239.

共引文献31

同被引文献14

  • 1董锡臣,付朝晖,张文众,黄宇光.反相高效液相色谱法测定罗哌卡因在犬血浆中的浓度[J].卫生研究,2006,35(2):230-232. 被引量:4
  • 2李雪宁,许剑安,陈伟力,徐红蓉,缪长虹.LC-MS/MS法测定手术患者中罗哌卡因注射液的血浓度及药动学[J].中国临床药学杂志,2006,15(5):283-286. 被引量:7
  • 3王珊娟,张马忠,周颖,刘万枫,宋琳,张洁,蔡美华,杭燕南.下腹部手术病人硬膜外注射甲磺酸罗哌卡因的药代动力学[J].中华麻醉学杂志,2006,26(9):810-812. 被引量:6
  • 4Andersen Lo,Husted H,Kristensen BB,et al.Analgesic efficacy of intracapsular and intea-articular local anaesthesia for knee arthroplasty[J].Anaesthesia,2010,65(9):904-12.
  • 5Axelsson K,Gupta A,Johanzon E,Berg E,et al.Intraarticular administration of ketorolac,morphine,and ropivacaine combined with intraerticular patient-controlled regional analgesia for pain relief after shoulder surgery:a randomized,double-blind study[J].Anesth Analg,2008,106(1):328-333.
  • 6Ala-Kokko TI,L?pp?nen A,Alahuhta S.Two instances of central nervous system toxicity in the same patient following repeated ropivacaine-induced brachial plexus block[J].Acts Anaesthesiol Scand,2000,44(5):623-626.
  • 7Reinikainen M,Hedman A,Pelkonen O,ECardiac arrest after inter-scalene brachial plexus block with ropivacaine and lidocaine[J].Acts Anaesthesiol Scand,2003,47(7):904-906.
  • 8Hansen TG,Ilett KF,Lim SI,et al.pharmacokinetica and clinical efficacy of long-term epidural ropivacaine infusion in children[J].Br J Anaesth,2000,85(3):347-353.
  • 9Andersen LO, Husted H, Kristensen BB, et al. Analgesic efficacy of intracapsular and intra-articular local anaesthesia for knee arthroplasty [J]. Anaesthesia, 2010, 65(9): 904.
  • 10Axelsson K, Gupta A, Johanzon E, et al. Intraarticular administration of ketorolac, morphine, and ropivacaine combined with intraarticular patientcontrolled regional analgesia for pain relief after shoulder surgery: a randomized, double-blind study[J]. Anesth Analg, 2008, 106(1): 328.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部